Aptevo Therapeutics Inc
Price
FilingsNewest: 8-K, Other eventsSep 24 →Insiders1 insider bought $20,134 in 1 open-market buy. No sales.→HoldersVanguard 0.9%Geode 0.8%Vanguard Fiduciary Trust 0.3%→Financing →PeersClosest companies: CTMX, HOWL, FATE→
From the filings
Figures
- Net income
- −$26.4Mlast 12 months
- Operating cash flow
- −$27.0Mlast 12 months
- Cash and equivalents
- $9.8Mat the last balance sheet
- Shares outstanding
- 1.4M shareson issue